About this document
Pharma Lec 5&6 by doctorf465 is a document available to read on EtoBox.
The document discusses Levetiracetam (Keppra), an anticonvulsant drug approved in 1999 for treating partial, myoclonic, and tonic-clonic seizures, often used as adjunct therapy. It highlights contraindications such as renal dysfunction and lists adverse effects including asthenia, infection, and behavioral issues in children. The document is prepared by Dr. Faruq A. Abdulrahman.
- Author
- doctorf465
- Language
- EN